Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000809202 | SCV000949345 | uncertain significance | Gluthathione synthetase deficiency | 2022-10-25 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 211 of the GSS protein (p.Gln211Glu). This variant is present in population databases (rs370351723, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with GSS-related conditions. ClinVar contains an entry for this variant (Variation ID: 653428). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GSS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001507987 | SCV001713858 | uncertain significance | not provided | 2021-05-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001507987 | SCV003800016 | uncertain significance | not provided | 2023-02-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001507987 | SCV004235234 | uncertain significance | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing |